1-20 of 30
Peter Johnson, MD
Close
Sort by
Articles

Using Interim PET to Direct Therapy for Early Hodgkin Lymphoma: Results from the Trials

Peter Johnson, MD, Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2016) 13 (1)
https://doi.org/10.1182/hem.V13.1.4825
Published: 2016
Articles

DUSP4: A New Tumor Suppressor in B-cell Lymphoma With Some Very Druggable Targets

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2015) 12 (5)
https://doi.org/10.1182/hem.V12.5.4320
Published: 2015
Articles

Immunomodulation: An Interesting Off-target Effect of Ibrutinib

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2015) 12 (3)
https://doi.org/10.1182/hem.V12.3.3904
Published: 2015
Articles

Memory Games in the Lymph Node: The Inflammatory Origins of Follicular Lymphoma

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2015) 12 (2)
https://doi.org/10.1182/hem.V12.2.3676
Published: 2015
Articles

Targeted Therapy in Lymphoproliferative Disorders (Excluding CAR T Cells)

Peter Johnson, MD, Jason Gotlib, MD, MS, Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2015) 12 (1)
https://doi.org/10.1182/hem.V12.1.3626
Published: 2015
Articles

FDG-PET as a Guide for Consolidation Radiotherapy in Primary Mediastinal Lymphoma

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2014) 11 (5)
https://doi.org/10.1182/hem.V11.5.3178
Published: 2014
Articles

Collective Action at the Cell Surface: Antibodies Club Together to Activate Complement

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2014) 11 (4)
https://doi.org/10.1182/hem.V11.4.2948
Published: 2014
Articles

JAK-STAT Signaling Goes Bad in Primary Mediastinal Lymphoma

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2014) 11 (3)
https://doi.org/10.1182/hem.V11.3.2746
Published: 2014
Articles

Unlocking Host Immunity to Lymphoma

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2014) 11 (2)
https://doi.org/10.1182/hem.V11.2.2560
Published: 2014
Articles

Take Me to the Liver: New Insights on Antibody Mechanisms

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2014) 11 (1)
https://doi.org/10.1182/hem.V11.1.2614
Published: 2014
Articles

Follicular Lymphoma Cells Spin a Web of Immunosuppression

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2013) 10 (6)
https://doi.org/10.1182/hem.V10.6.1018
Published: 2013
Articles

Hodgkin Lymphoma: Antibody-Drug Conjugate Tested in the Front Line

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2013) 10 (5)
https://doi.org/10.1182/hem.V10.5.1028
Published: 2013
Articles

Stitching Trainers Together to Subtype Diffuse Large B-Cell Lymphoma

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2013) 10 (3)
https://doi.org/10.1182/hem.V10.3.1064
Published: 2013
Articles

Predicting Clinical Outcome in Patients With Hodgkin Lymphoma

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2013) 10 (2)
https://doi.org/10.1182/hem.V10.2.1075
Published: 2013
Articles

Inhibiting EZH2 in Lymphoma: Breaking the Silence of the Genes

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2013) 10 (1)
https://doi.org/10.1182/hem.V10.1.1100
Published: 2013
Articles

Another NOTCH : Splenic Marginal Zone Lymphoma Sequenced

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2012) 9 (6)
https://doi.org/10.1182/hem.V9.6.1117
Published: 2012
Articles

Follicular Lymphoma: The Environment as the Target

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2012) 9 (5)
https://doi.org/10.1182/hem.V9.5.1121
Published: 2012
Articles

Genetic Horizon Scanning in Large B-Cell Lymphoma

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2012) 9 (4)
https://doi.org/10.1182/hem.V9.4.1145
Published: 2012
Articles

Primed for Destruction: Why are Some Cells More Chemosensitive Than Others?

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2012) 9 (3)
https://doi.org/10.1182/hem.V9.3.1164
Published: 2012
Articles

Searching for Second Events in Follicular Lymphoma: A New Target for Therapy

Peter Johnson, MD
Journal: The Hematologist
The Hematologist (2012) 9 (1)
https://doi.org/10.1182/hem.V9.1.1199
Published: 2012